Lv2
128 积分 2024-06-03 加入
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
8个月前
已完结
Nonlinear dendritic integration of sensory and motor input during an active sensing task
8个月前
已完结
皖公网安备34019202002308
